[go: up one dir, main page]

Bua, 2016 - Google Patents

Parvovirus B19: Virus-Cell Interactions, Pathogenetic Mechanisms and Development of Compounds with Antiviral Activity

Bua, 2016

View PDF
Document ID
3196473736432788364
Author
Bua G
Publication year

External Links

Snippet

The pathogenic Parvovirus B19 is characterized by a strict adaptation to erythroid progenitor cells (EPCs), a heterogeneous population of differentiating cells. The aim of the work was the characterization of B19V infection dynamics in EPCs in dependence on the cell …
Continue reading at amsdottorato.unibo.it (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—AIDS or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Similar Documents

Publication Publication Date Title
Gallinella Parvovirus B19 achievements and challenges
Broliden et al. Clinical aspects of parvovirus B19 infection
Qiu et al. Human parvoviruses
Fontana et al. Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient
Rinaldo et al. The human polyomavirus BK (BKP yV): virological background and clinical implications
Corcoran et al. Advances in the biology, diagnosis and host–pathogen interactions of parvovirus B19
Ambalathingal et al. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies
Chen et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy
Heegaard et al. Human parvovirus B19
Kojaoghlanian et al. The impact of adenovirus infection on the immunocompromised host
Zanella et al. Beyond cytomegalovirus and Epstein-Barr virus: a review of viruses composing the blood virome of solid organ transplant and hematopoietic stem cell transplant recipients
Tanaka et al. Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient
Bültmann et al. Parvovirus B19: a pathogen responsible for more than hematologic disorders
Chevillotte et al. A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes
Li et al. Production of infectious dromedary camel hepatitis E virus by a reverse genetic system: Potential for zoonotic infection
Kwon et al. Serological prevalence, genetic identification, and characterization of the first strains of avian hepatitis E virus from chickens in Korea
Cook Polyomaviruses
Peterlana et al. Serologic and molecular detection of human Parvovirus B19 infection
Colmegna et al. Parvovirus B19: its role in chronic arthritis
Malm et al. Norovirus-specific memory T cell responses in adult human donors
Shih et al. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus
Hurtado et al. The use of COS-1 cells for studies of field and laboratory African swine fever virus samples
Hawkinson et al. Respiratory viruses: influenza, RSV, and adenovirus in kidney transplantation
Lee et al. Other viral pneumonias: coronavirus, respiratory syncytial virus, adenovirus, hantavirus
Jones et al. Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule